Spread the love

A recent study from the Department of Pathology, Columbia University, New York, New York, USA;  Department of Dermatology, Columbia University, New York, New York, USA; and Department of Medicine, Columbia University, New York, New York, USA shows that Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition.”

This study was published in the August, 17 2014 issue of Nature Medicine (The number 1 journal in Medicine with an IF of ~35) by Prof. Clynes R, Xing L and others from Columbia University, New York,  USA.

On the foundation of this interesting finding, Dr L Boominathan, Director-cum-chief Scientist of GBMDreports here that: Natural product-based therapy for Alopecia areata: Antrocin reverses Alopecia areata via down regulation of its target genes.  This study suggests, for the first time, that Antrocin, by down regulating its target genes, they may reverse alopecia areata.   Together, this study suggests that pharmacological formulations encompassing “Antrocin or its analogues” may be used to treat Alopecia areata.

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, L., Natural product-based therapy for Alopecia areata: Antrocin reverses Alopecia areata via down regulation of its target genes, Genome-2-Bio-Medicine Discovery center (GBMD), 20/September/2014, 6,24 am,  http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation


Spread the love